PTCT vs MTVA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PTCT Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PTC Therapeutics, Inc. (PTCT) driven by superior Valuation, Growth & Margin while MTVA counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PTCT trades at 17.7x Forward P/E with 21.5% operating margin (+69.6% YoY revenue) versus MTVA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PTCT sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro) against MTVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PTCT | MTVA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.9B | $7.2M | Larger Scale | PTCT |
| Trailing P/E Ratio Valuation | 18.0x | N/M | Lower Multiple | PTCT |
| Forward P/E Ratio Valuation | 17.7x | N/M | Lower Multiple | PTCT |
| Revenue Growth (YoY) Growth | +69.6% | +0.0% | Higher Growth | PTCT |
| Operating Margin (TTM) Profitability | 21.5% | 0.0% | Higher Margin | PTCT |
| Net Profit Margin Profitability | -9.2% | 0.0% | Higher Margin | MTVA |
| Return on Equity (ROE) Capital Efficiency | -7740.1% | -175.7% | Higher ROE | MTVA |
| 52-Week Range Position Momentum | 1% ($56โ$91) | 4% ($1โ$13) | Stronger Trend | MTVA |
| Beta / 30D Volatility Risk Regime | 0.83ฮฒ ยท 58% Vol | 1.30ฮฒ ยท 166% Vol | Lower Realized Risk | PTCT |
| Unified Institutional Score Composite Signal | 36.3 / 100 (SELL) | 48.0 / 100 (HOLD) | Higher Composite | MTVA |